hs ctni test

hs-cTnI kit  is applied for early diagnosis and monitoring of myocardial injury and acute myocardial infarction. hs-cTnI OEM kit utilizes a three-antibody sandwich immunoassay and is applicable to chemiluminescence platforms. Specific antibodies target different cTnI epitopes to capture trace plasma hs-cTnI, delivering high sensitivity and specificity. Calibrated with high-purity recombinant cTnI, the assay provides accurate and stable quantitative results. Serving as the gold standard for acute myocardial infarction diagnosis, it supports early identification and dynamic monitoring of myocardial injury for clinical auxiliary diagnosis. Ischemia and hypoxia induce myocardial degeneration and necrosis, enabling cTnI leakage into circulation. Plasma cTnI surges 3–12 hours after injury and remains elevated for over one week. In MI patients, cTnI rises early, peaks at 18 h, and stays abnormal for 6–8 days. As a universally accepted biomarker, cTnI detects myocardial injury and is the gold standard for AMI diagnosis. ★Bulk reagents are available with matching raw materials.